Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
EMD Serono
EMD Serono
Ohio State University Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Centre hospitalier de l'Université de Montréal (CHUM)
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
University of Iowa
Centre Francois Baclesse
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center